Chronic hepatitis B: Update 2009

By A. Lok, B. McMahon. Hepatology, 2009

2,848 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/4f974e048c7dd8d7e3a9404f21aa7bbfa9bafb64

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. RS Brown
2. JB Wong
3. NA Terrault
4. M. Jonas
5. B. McMahon
6. NH Bzowej
7. JP Hwang
8. A. Lok

Citations in the corpus

• Molecular Biology of Hepatitis B Virus Infection (2015, neutral): “For this and other reasons, antiviral therapy has not been recommended for patients still in the immune tolerant phase of infection (Lok and McMahon, 2009).”
• Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (2018, background): “Anti-HBc may be the only marker of HBV infection during the window phase of acute hepatitis B; these persons should test positive for antiHBc immunoglobulin M.((37,38)) iv.”